New research from a UK charity has found that lung rehabilitation programmes have been cancelled throughout the Covid-19 pandemic despite an expected rise in respiratory complications as a result of the virus. The survey of UK patients and carers, conducted by the Pulmonary Fibrosis Trust, reports that the cancellation of treatments has affected more than one third (82.9 per cent) of pulmonary fibrosis patients. Pulmonary fibrosis (PF) is an incurable disease that causes scarring of the lungs and makes breathing increasingly difficult, affecting around 70,000 people in the UK and with an average survival of three to five years. Emerging data reveals that PF could be a long-term respiratory consequence of Covid-19 due to the similar lung-scarring effect.